Prime Medicine, Inc.
Prime Medicine, Inc. (PRME) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 90 transactions totaling $162.6M, demonstrating a bullish sentiment with $122.6M in net insider flow. The most recent transaction on Feb 23, 2026 involved a transaction of 140,000 shares valued at $0.
PRME Insider Activity Summary
Who Is Buying PRME Stock?
No significant insider buying has been recorded for PRME in the recent period.
Who Is Selling PRME Stock?
No significant insider selling has been recorded for PRME in the recent period.
Is Prime Medicine, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PRME is bullish with an Insider Alignment Score of 88/100 and a net flow of $122.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
PRME Frequently Asked Questions
Understanding PRME Insider Activity
Insider trading at Prime Medicine, Inc. (PRME) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading PRME stock, having executed 90 transactions in the past 90 days. The most active insider is Robert Nelsen (Executive), who has made 7 transactions totaling $43.6M.
Related Tools
Track Prime Medicine, Inc. Insider Activity
Get notified when executives and directors at PRME file new Form 4 transactions